SCHEMBL3346090

SCHEMBL3346090

CCC(CC)(c1cccc2ccccc12)P(=O)(O)O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACP3 P15309 4/20 0.61
PTPRC P08575 1/20 0.43
PTK2B Q14289 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.40
HPGD P15428 1/20 0.40
CDC14B O60729 1/20 0.39
CDC14A Q9UNH5 1/20 0.39
CA12 O43570 1/20 0.38
CA2 P00918 1/20 0.38
MMP2 P08253 1/20 0.38
MMP9 P14780 1/20 0.38
MMP8 P22894 1/20 0.38
MMP14 P50281 1/20 0.38
CA14 Q9ULX7 1/20 0.38
PLK1 P53350 1/20 0.38
PTPN1 P18031 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11762883 0.90 ACP3 (0.48) ACP3PTPRCCDC14BCDC14APTPN1
SCHEMBL27974808 0.86 ACP3 (0.47) ACP3PTPRCKDM4EHPGDCDC14B
SCHEMBL1585204 0.84 TSHR (0.41) ACP3CDC14BCDC14ACA2PTPN1
SCHEMBL1294409 0.81 ACP3 (0.42) ACP3PTPRCKDM4ELMNAHPGD
SCHEMBL6703082 0.79 TSHR (0.38) ACP3CDC14BCDC14APTPN1MEN1
SCHEMBL1035151 0.77 PGK1 (0.39) ACP3L3MBTL1HPGDPTPN1MEN1
SCHEMBL2228173 0.77 FDPS (0.41) ACP3PTPN1MEN1KMT2APGK1
SCHEMBL8938007 0.76 ACP3 (1.00) ACP3PTPRCKDM4EHPGDMEN1
SCHEMBL11758540 0.76 ACP3 (0.46) ACP3PTPRCKDM4ELMNAHPGD
SCHEMBL2034011 0.76 FDPS (0.45) ACP3KDM4EHPGDPTPN1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2334669-B1 HETEROCYCLYL-SUBSTITUTED THIAZOLES AS PLANT PROTECTION AGENTS BAYER IP GMBH (DE) 2015-12-23 EP disclosed
US-9067886-B2 Compounds having semiconducting properties and related compositions and devices POLYERA CORPORATION (US) 2015-06-30 US disclosed
US-20130146851-A1 Compounds Having Semiconducting Properties and Related Compositions and Devices POLYERA CORPORATION (US) 2013-06-13 US disclosed
WO-2012096538-A2 TIN-CENTERED DENDRIMER COMPOUND, AND ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING SAME 중앙대학교 산학협력단 (KR) 2012-07-19 WO disclosed
WO-2010037479-A1 HETEROCYCLYL-SUBSTITUTED THIAZOLES AS PLANT PROTECTION AGENTS BAYER CROPSCIENCE AG (DE) 2010-04-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130146851-A1 Compounds Having Semiconducting Properties and Related Compositions and Devices NES, KCNN2, EPCAM ACP3 2256/4885PTPRC 405/4885PTK2B 3755/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.